Exploratory study of blood biomarkers in patients with post-stroke epilepsy
- 1 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 9 (3) , 763-771
Abstract
Introduction: In addition to clinical factors, blood-based biomarkers can provide useful information on the risk of developing post-stroke epilepsy (PSE). Our aim was to identify serum biomarkers at stroke onset that could contribute to predicting patients at higher risk of PSE. Patients and methods: From a previous study in which 895 acute stroke patients were followed-up, 51 patients developed PSE. We selected 15 patients with PSE and 15 controls without epilepsy. In a biomarker discovery setting, 5 Olink panels of 96 proteins each, were used to determine protein levels. Biomarkers that were down-regulated and overexpressed in PSE patients, and those that showed the strongest interactions with other proteins were validated using an enzyme-linked immunosorbent assay in samples from 50 PSE patients and 50 controls. A ROC curve analysis was used to evaluate the predictive ability of significant biomarkers to develop PSE. Results: Mean age of the PSE discovery cohort was 68.56 ± 15.1, 40% women and baseline NIHSS 12 [IQR 1–25]. Nine proteins were down-expressed: CASP-8, TNFSF-14, STAMBP, ENRAGE, EDA2R, SIRT2, TGF-alpha, OSM and CLEC1B. VEGFa, CD40 and CCL4 showed greatest interactions with the remaining proteins. In the validation analysis, TNFSF-14 was the single biomarker showing statistically significant downregulated levels in PSE patients (p = 0.006) and it showed a good predictive capability to develop PSE (AUC 0.733, 95% CI 0.601–0.865). Discussion and conclusion: Protein expression in PSE patients differs from that of non-epileptic stroke patients, suggesting the involvement of several different proteins in post-stroke epileptogenesis. TNFSF-14 emerges as a potential biomarker for predicting PSE.Keywords
Funding Information
- La Fundació La Marató de TV3 (Reg.84/240 proj 201702)
- La Fundació La Marató de TV3 (Reg.84/240 proj 201702)
This publication has 31 references indexed in Scilit:
- Cytokine-chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosisEpilepsy Research, 2022
- Correlation of blood biomarkers with early-onset seizures after an acute stroke eventEpilepsy & Behavior, 2020
- Acute symptomatic seizures and epilepsy after mechanical thrombectomyEpilepsy & Behavior, 2020
- Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated severe blunt traumatic brain injuryClinica Chimica Acta, 2019
- VEGF treatment during status epilepticus attenuates long-term seizure-associated alterations in astrocyte morphologyEpilepsy & Behavior, 2017
- Distinct inflammatory responses differentiate cerebral infarct from transient ischaemic attackJournal of Clinical Neuroscience, 2016
- The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesImmunity, 2016
- Evidence for involvement of the CD40/CD40L system in post-stroke epilepsyNeuroscience Letters, 2014
- Targeting the LIGHT-HVEM Pathway2009
- Vascular Endothelial Growth Factor (VEGF) in Seizures:2004